Back
EHRA Premium Access

Assessing the risk of digitalis intoxication in concomitant users of dronedarone and digoxin in real-world practice

Session: Poster session 1 - Atrial Fibrillation - Treatment
Topic: Rhythm Control, Antiarrhythmic Drugs
Speaker: Doctor C. Wu (Bridgewater, US)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Chuntao Wu

Sanofi, Bridgewater (United States of America)
0 follower

47 more presentations in this session

Predictive factors of arrhythmia-recurrence at the one-year after radiofrequency catheter ablation for paroxysmal atrial fibrillation: insight from kansai plus atrial fibrillation registry.

Speaker: Doctor M. Tanaka (Kobe, JP)

Access
Abstract
Like
Thumbnail

Efficacy of high-power ablation based on ablation index on pulmonary vein isolation for atrial fibrillation

Speaker: Doctor A. Kobori (Kobe, JP)

Access
Abstract
Like
Thumbnail

Effectiveness of dragging laser ablation for pulmonary vein isolation

Speaker: Doctor Y. Sasaki (Kobe, JP)

Access
Abstract
Like
Thumbnail

Low body mass index and recurrence of atrial fibrillation after cryobaloon ablation: multicenter BREAK-AF registry

Speaker: Doctor J. Morita (Sapporo, JP)

Access
Abstract
Like
Thumbnail

The assessment of pulmonary vein potentials using the novel achieve advance during cryoballoon ablation of atrial fibrillation

Speaker: Doctor G. Mugnai (Verona, IT)

Access
Like
Thumbnail

Access the full session

Poster session 1 - Atrial Fibrillation - Treatment

Speakers: Doctor C. Wu, Doctor M. Tanaka, Doctor A. Kobori, Doctor Y. Sasaki, Doctor J. Morita...
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources